Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-05-17 4:33 pm Sale | 13G | INHIBRX INC INBX | RA CAPITAL MANAGEMENT L.P. | 0 0% | -2,129,003 (Position Closed) | View |
| 2021-05-17 4:32 pm Sale | 13G | LYRA THERAPEUTICS INC LYRA | RA CAPITAL MANAGEMENT L.P. | 0 0% | -815,849 (Position Closed) | View |
| 2021-05-06 4:33 pm Purchase | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA CAPITAL MANAGEMENT L.P. | 3,968,583 14.4% | 3,968,583 (New Position) | View |
| 2021-05-05 4:39 pm Purchase | 13G | SERES THERAPEUTICS INC MCRB | RA CAPITAL MANAGEMENT L.P. | 4,702,206 5.1% | 4,702,206 (New Position) | View |
| 2021-04-16 4:34 pm Purchase | 13D | ACHILLES THERAPEUTICS PLC ACHL | RA CAPITAL MANAGEMENT L.P. | 5,014,687 12.34% | 5,014,687 (New Position) | View |
| 2021-04-07 4:32 pm Unchanged | 13G | Trillium Therapeutics Inc. TRIL | RA CAPITAL MANAGEMENT L.P. | 5,290,481 5.1% | 0 (Unchanged) | View |
| 2021-04-07 4:31 pm Unchanged | 13G | ATEA PHARMACEUTICALS INC AVIR | RA CAPITAL MANAGEMENT L.P. | 5,368,451 6.5% | 0 (Unchanged) | View |
| 2021-04-07 4:30 pm Purchase | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | RA CAPITAL MANAGEMENT L.P. | 2,378,325 6.5% | 2,378,325 (New Position) | View |
| 2021-03-30 4:43 pm Purchase | 13G | VAXCYTE INC PCVX | RA CAPITAL MANAGEMENT L.P. | 3,865,808 7.53% | 155,109 (+4.18%) | View |
| 2021-03-29 4:30 pm Purchase | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | RA CAPITAL MANAGEMENT L.P. | 6,640,417 11.5% | 6,640,417 (New Position) | View |
| 2021-03-24 4:30 pm Purchase | 13G | PHASEBIO PHARMACEUTICALS INC C PHAS | RA CAPITAL MANAGEMENT L.P. | 2,850,000 6% | 2,850,000 (New Position) | View |
| 2021-03-23 4:32 pm Purchase | 13D | SOLID BIOSCIENCES INC SLDB | RA CAPITAL MANAGEMENT L.P. | 12,367,873 11.6% | 2,391,304 (+23.97%) | View |
| 2021-03-15 4:38 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | RA CAPITAL MANAGEMENT L.P. | 388,385 6.3% | 388,385 (New Position) | View |
| 2021-03-09 4:30 pm Purchase | 13G | ARYA SCIENCES ACQUISITION CORP ARYD | RA CAPITAL MANAGEMENT L.P. | 1,000,000 6.7% | 1,000,000 (New Position) | View |
| 2021-03-02 4:32 pm Purchase | 13D | SATSUMA PHARMACEUTICALS INC CO STSA | RA CAPITAL MANAGEMENT L.P. | 5,914,252 18.8% | 1,232,394 (+26.32%) | View |
| 2021-02-19 4:30 pm Purchase | 13D | VOR BIOPHARMA INC.COM VOR | RA CAPITAL MANAGEMENT L.P. | 11,120,973 30% | 11,120,973 (New Position) | View |
| 2021-02-16 4:39 pm Sale | 13G | RELMADA THERAPEUTICS INC P RLMD | RA CAPITAL MANAGEMENT L.P. | 0 0% | -761,666 (Position Closed) | View |
| 2021-02-16 4:39 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | RA CAPITAL MANAGEMENT L.P. | 12,315,213 12.6% | 1,950,555 (+18.82%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | NOVAVAX INC NVAX | RA CAPITAL MANAGEMENT L.P. | 3,788,564 6% | 3,788,564 (New Position) | View |
| 2021-02-16 4:39 pm Sale | 13G | PREVAIL THERAPEUTICS INC PRVL | RA CAPITAL MANAGEMENT L.P. | 0 0% | -3,363,605 (Position Closed) | View |